Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;12(1):31-37.
doi: 10.1177/1753495X18793484. Epub 2018 Sep 19.

Mixed connective tissue disease in pregnancy: A case series and systematic literature review

Marie-Lou Tardif  1 , Michèle Mahone  1
Affiliations

Mixed connective tissue disease in pregnancy: A case series and systematic literature review

Marie-Lou Tardif et al. Obstet Med. 2019 Mar.

Abstract

Objective: To investigate the impact of medical and obstetric complications associated with mixed connective tissue disease (MCTD) in pregnancy.

Method: We analyzed 68 pregnancies from a systematic literature review and 12 pregnancies affected by MCTD at our centre between 1986 and 2015 for medical and obstetric complications.

Results: During pregnancy 37.1% had active MCTD and 26.7% had relapsed. Maternal complications included caesarean section (31.1%, n = 19), preeclampsia (17.6%, n = 13), thromboembolism events, and death (2.5%, n = 2 for each). Fetal complications included prematurity (48.1%, n = 25), intrauterine growth restriction (38.3%, n = 19), and neonatal lupus (28.6%, n = 18, including chondrodysplasia punctata). More than half (n = 10) of the neonatal lupus cases were explained by anti-U1RNP only. The perinatal mortality rate was 17.7% (n = 14). Pregnant women with active disease had higher rates of prematurity (OR = 7.60; 95%CI [1.93; 29.95]) and perinatal death (OR = 16.83; 95%CI [1.90; 147.70]).

Conclusion: MCTD in pregnancy puts women at risk of medical and obstetric complications, and disease activity probably increases this risk.

Keywords: Mixed connective tissue disease; Sharp syndrome; U1RNP antibody; chondrodysplasia punctata; neonatal systemic lupus erythematosus; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Case selection. W: women; P: pregnancy; Dx: diagnosis; PP: post-partum; APLS: antiphospholipid syndrome.
See this image and copyright information in PMC

References

    1. Kitridou RC. Pregnancy in mixed connective tissue disease. Rheum Dis Clin North Am 2005; 31: 497–508, vii. - PubMed
    1. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328–334. - PubMed
    1. Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can 2014; 36: e1–e27. - PubMed
    1. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: E35. - PubMed
    1. Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 2010; 72: 223–225. - PubMed

LinkOut - more resources